Armenia vs China: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Armenia
0.1%
in 2024
China
0.1%
in 2024
Armenia rank
112th
China rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Armenia
- China
How they compare
Armenia currently reports 0.1% against 0.1% in China, a difference of 0.0%.
Across all 10 years both countries report, China has been ahead every year.
Armenia ranks 112th and China ranks 112th of 215 countries.
Head to head by decade
| Decade | Armenia | China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.0% | — |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Armenia or China?
- Armenia, at 0.1% against 0.1% in China as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Armenia and China?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and China?
- 10 years are reported by both, from 2015 to 2024.
- How do Armenia and China rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Armenia ranks 112th and China ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.